|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Anadys Reports Interim Hep C Drug Data, Ligand Collects Milestone Payment, Phenomix’s Diabetes Drug Shows Promise, & More San Diego Life Sciences News
|
Denise Gellene |
04/22/10 |
San Diego
|
|
Scandal, Swine Flu, Shareholder Disputes, and More: 2009 Was Quite a Year for San Diego’s Life Sciences Industry
|
Denise Gellene |
12/22/09 |
San Diego
|
|
Swine Flu Could Benefit Some Biomedical Companies, Local Biotechs Are Looking Healthier, Arena Happy With Obesity Drug Results, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/24/09 |
San Diego
|
|
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine
|
Luke Timmerman |
09/03/09 |
National
|
|
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines
|
Luke Timmerman |
08/25/09 |
San Diego
|
|
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent
|
Luke Timmerman |
07/30/09 |
Seattle
|
|
Sequenom Discloses SEC Probe, How Evoke Pharma Got its Drug, Illumina Sales Fall Short, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
07/02/09 |
San Diego
|
|
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment
|
Luke Timmerman |
06/09/09 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.